CD4+ T cells from all postvaccination cohorts produced similar frequencies of IFN-γ, TNF-α, and IL-2, indicating broad polyfunctionality regardless of MS treatment status (Figure 4C). This evidence concerns the gene CD4 and myeloid sarcoma.